AI Startup Latest Funding Deal: Cohere raised $500M Series D round

Artificial Intelligence | Machine Learning | Machine Perception inveox | Automating Histopathology making Cancer Diagnoses Faster

Healthcare, Medical Devices, Digital Health, Pathology, Patient Care, Cancer Garching Bei Munich, Bayern, Germany

Artificial Intelligence | Machine Learning | Machine Perception

inveox | Automating Histopathology making Cancer Diagnoses Faster

Healthcare, Medical Devices, Digital Health, Pathology, Patient Care, Cancer

Garching Bei Munich, Bayern, Germany

inveox GmbH, founded in 2017,develops systems to digitize, automate and connect pathology laboratories. With an innovative automation system for sample preparation in histopathology, inveox increases efficiency and safety in pathology laboratories. As a result, the risk of operational irregularities and potential misdiagnoses are significantly reduced and the patient safety – especially in cancer diagnostics – greatly improved. One out of every two people will confront a cancer diagnosis at some point in their life. That’s why each and every cancer test needs to be quick, safe and reliable. Many people hear the word ‘pathology’ and think ‘autopsies’. But at its core, histopathology (the science of studying body tissue in relation to disease) works to save lives. That’s why inveox is bringing technology and automation to histopathology labs. Our system strengthens the safety and reliability of cancer diagnostics, and we boost the efficiency and productivity of labs by allowing them to process more samples in less time.